三重阴性乳腺癌的表观遗传改变及其对诊断和治疗的临床影响
1Department of Biological Sciences, Keimyung University College of Natural Sciences, Daegu 42601, Republic of Korea.
Journal of Cancer
|October 6, 2025
概括
三重阴性乳腺癌 (TNBC) 在有限的治疗方法下具有侵略性. 在TNBC的表观遗传变化为开发新疗法提供了有希望的目标,以改善患者的生存和生活质量.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 乳腺癌是女性癌症死亡的主要原因,三阴性乳腺癌 (TNBC) 是最具攻击性的亚型.
- 由于TNBC缺乏雌激素受体 (ER),孕激素受体 (PR) 和HER2表达,导致治疗选择有限和预后不佳.
- 人们越来越认识到表观遗传失调是TNBC发展和进展的关键驱动因素.
研究的目的:
- 提供对TNBC特异性表观遗传变化的最新进展的全面审查.
- 突出表观遗传机制在TNBC病变发生中的作用.
- 探索针对表观遗传修饰的潜在临床应用,以改善TNBC治疗.
主要方法:
- 关于TNBC表观遗传学的最近研究的文献综述.
- 对表观遗传机制的分析,包括DNA甲基化,基因素修饰和非编码RNA.
- 专注于将表观遗传变化与TNBC临床特征和治疗策略联系起来的研究.
主要成果:
- 在TNBC中,表观遗传机制,如DNA甲基化,基因素修饰和ncRNA沉默,至关重要.
- 这些表观遗传变化与TNBC的攻击性行为和转移潜力有关.
- 向表观遗传通路为TNBC的新型治疗干预提供了一个有希望的途径.
结论:
- 表观遗传学研究为TNBC生物学和进展提供了重要的见解.
- 了解TNBC表观遗传变化是开发个性化治疗策略的关键.
- 针对表观遗传学有望改善TNBC患者的生存率和生活质量.
相关概念视频
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


